Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Biochemistry|February 1, 2006
Impact of naturally occurring variants of HCV protease on the binding of different classes of protease inhibitorsXiao Tong, Zhuyan Guo, Jacquelyn Wright-Minogue, et al.Bioorganic & Medicinal Chemistry Letters|January 26, 2010
Semi-synthetic aristolactams--inhibitors of CDK2 enzymeVinod R Hegde, Scott Borges, Haiyan Pu, et al.Journal of Medicinal Chemistry|February 3, 2006
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocyclesKevin X Chen, F George Njoroge, Ashok Arasappan, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocketRobert D Mazzola, Zhaoning Zhu, Lisa Sinning, et al.Journal of Molecular Biology|December 9, 2003
Crystal structure of the catalytic domain of human ADAM33Peter Orth, Paul Reichert, Wenyan Wang, et al.Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 2Marc Labroli, Kamil Paruch, Michael P Dwyer, et al.Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1Michael P Dwyer, Kamil Paruch, Marc Labroli, et al.Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitorsMichael P Dwyer, Kamil Paruch, Carmen Alvarez, et al.Biopolymers|October 17, 2007
Structure-guided discovery of cyclin-dependent kinase inhibitorsThierry O Fischmann, Alan Hruza, José S Duca, et al.Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of hydantoin TACE inhibitorsWensheng Yu, Zhuyan Guo, Peter Orth, et al.Pageof 4